Cargando…
Reduction of Submental Fat Continues Beyond 28 Days After ATX-101 Treatment: Results From a Post hoc Analysis
Autores principales: | Dover, Jeffrey S., Shridharani, Sachin M., Bloom, Jason D., Somogyi, Christine, Gallagher, Conor J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221411/ https://www.ncbi.nlm.nih.gov/pubmed/29419542 http://dx.doi.org/10.1097/DSS.0000000000001484 |
Ejemplares similares
-
Novel Expanded Safe Zone for Reduction of Submental Fullness with ATX-101 Injection
por: Shridharani, Sachin M., et al.
Publicado: (2019) -
Abstract: Alopecia in Male Patients Treated with ATX-101 (Deoxycholic Acid) for Submental Fullness
por: Shridharani, Sachin M., et al.
Publicado: (2017) -
Abstract 33: Localized Injection Site Alopecia in Male Patients After Treatment of Submental Fat with ATX-101 (Deoxycholic Acid)
por: Shridharani, Sachin M., et al.
Publicado: (2018) -
Abstract: Novel Expanded Safe Zone System for Treatment of Submental Fullness with ATX-101 (Deoxycholic Acid)
por: Shridharani, Sachin M., et al.
Publicado: (2017) -
Best Clinical Practices with ATX-101 for Submental Fat Reduction: Patient-related Factors and Physician Considerations
por: Teller, Craig F., et al.
Publicado: (2021)